Literature DB >> 9729513

Dehydration reverses vasopressin antagonist-induced diuresis and aquaporin-2 downregulation in rats.

D Marples1, B M Christensen, J Frokiaer, M A Knepper, S Nielsen.   

Abstract

To examine the involvement of vasopressin and dehydration in the regulation of aquaporin-2 (AQP2) expression in rat kidney, we investigated the effects of treatment for 60 h with the specific V2-receptor antagonist OPC-31260 (OPC), alone and in conjunction with dehydration for the last 12 h. Changes in AQP2 protein and mRNA expression in kidney inner medulla were determined by Western and Northern blotting, and AQP2 distribution was analyzed by immunocytochemistry and immunoelectron microscopy. Treatment with OPC increased urine output fourfold, with a reciprocal decrease in urine osmolality. AQP2 expression decreased to 52 +/- 11% of control levels (n = 12, P < 0.05), and AQP2 was found predominantly in intracellular vesicles in collecting duct principal cells. This is consistent with efficient blockade of the vasopressin-induced AQP2 delivery to the plasma membrane and with the observed increased diuresis. Consistent with this, AQP2 mRNA levels were also reduced in response to prolonged OPC treatment (30 +/- 10% of control levels, n = 9). Five days of treatment with furosemide, despite producing even greater polyuria than OPC, was not associated with downregulation of AQP2 levels, demonstrating that AQP2 downregulation is not secondary to increased urine flow rate or loss of medullary hypertonicity. During 12-h thirsting in the continued presence of OPC, urine output dropped dramatically, to levels not significantly different from that seen in (nonthirsted) control animals. In parallel with this, AQP2 levels rose to control levels. Control experiments confirmed continued effective receptor blockade. These results indicate that the V2-receptor antagonist causes a modest decrease in AQP2 expression that is not a consequence of increased urine flow rate or washout of medullary hypertonicity. However, this decrease is much less marked than that seen in some forms of acquired nephrogenic diabetes insipidus. In conjunction with the effects of thirsting, this suggests that modulation of AQP2 expression is mediated partly, but not exclusively, via V2 receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729513     DOI: 10.1152/ajprenal.1998.275.3.F400

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  alphaENaC-mediated lithium absorption promotes nephrogenic diabetes insipidus.

Authors:  Birgitte Mønster Christensen; Annie Mercier Zuber; Johannes Loffing; Jean-Christophe Stehle; Peter M T Deen; Bernard C Rossier; Edith Hummler
Journal:  J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 10.121

2.  Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene.

Authors:  J Yun; T Schöneberg; J Liu; A Schulz; C A Ecelbarger; D Promeneur; S Nielsen; H Sheng; A Grinberg; C Deng; J Wess
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

3.  Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus.

Authors:  Emma T B Olesen; Michael R Rützler; Hanne B Moeller; Helle A Praetorius; Robert A Fenton
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

4.  Distribution of AQP2 and AQP3 water channels in human tissue microarrays.

Authors:  A Mobasheri; S Wray; D Marples
Journal:  J Mol Histol       Date:  2005-02       Impact factor: 2.611

5.  Functional requirement of aquaporin-5 in plasma membranes of sweat glands.

Authors:  Lene N Nejsum; Tae-Hwan Kwon; Uffe B Jensen; Ornella Fumagalli; Jørgen Frøkiaer; Carissa M Krane; Anil G Menon; Landon S King; Peter C Agre; Søren Nielsen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

6.  Acute hypertonicity alters aquaporin-2 trafficking and induces a MAPK-dependent accumulation at the plasma membrane of renal epithelial cells.

Authors:  Udo Hasler; Paula Nunes; Richard Bouley; Hua A J Lu; Toshiyuki Matsuzaki; Dennis Brown
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

7.  Changes of renal AQP2, ENaC, and NHE3 in experimentally induced heart failure: response to angiotensin II AT1 receptor blockade.

Authors:  Sophie C Lütken; Soo Wan Kim; Thomas Jonassen; David Marples; Mark A Knepper; Tae-Hwan Kwon; Jørgen Frøkiaer; Søren Nielsen
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23

8.  Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis.

Authors:  P Ivarsen; J Frøkiaer; N K Aagaard; E F Hansen; F Bendtsen; S Nielsen; H Vilstrup
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

9.  Tolvaptan as a tool in renal physiology.

Authors:  Carlos A Miranda; Jae Wook Lee; Chung-Lin Chou; Mark A Knepper
Journal:  Am J Physiol Renal Physiol       Date:  2013-12-04

Review 10.  Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases.

Authors:  Emma T B Olesen; Robert A Fenton
Journal:  Nat Rev Nephrol       Date:  2021-07-01       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.